1106 studies found for:    Ovarian Cancer: Clinical Trials
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: cediranib
2 Recruiting A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Device: ThermalCore Hyperthermia System
3 Recruiting Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence
Condition: First Recurrence of Ovarian Cancer
Interventions: Procedure: Secondary citoreduction;   Procedure: Hyperthermic intra-peritoneal chemotherapy (HIPEC)
4 Completed
Has Results
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Peritoneal Neoplasms
Intervention: Drug: Docetaxel and Gemcitabine
5 Unknown  Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
Conditions: Ovarian Epithelial Cancer;   Ovarian Germ Cell Tumor
Interventions: Other: cytology specimen collection procedure;   Procedure: ultrasound imaging;   Other: screening questionnaire administration
6 Active, not recruiting Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer
Condition: Platinum-resistant Advanced Ovarian Cancer
Intervention: Drug: Pazopanib
7 Active, not recruiting Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: Early detection
8 Unknown  Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
9 Completed Assess Cancer in Ovarian Tumors With Biomarkers.
Condition: Ovarian Tumor
Intervention: Procedure: Blood Draw
10 Recruiting ICON8: Weekly Chemotherapy in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel
11 Completed Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Leukemia;   Liver Cancer;   Lymphoma;   Neuroblastoma;   Ovarian Cancer;   Psychosocial Effects of Cancer and Its Treatment;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Procedure: psychosocial assessment and care
12 Unknown  Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
Conditions: Cancer.;   Melanoma.;   Ovarian Cancer.;   Lung Cancer.
Interventions: Biological: NY-ESO-1 combined with MPLA;   Biological: NY-ESO-1 combined with MPLA vaccine
13 Completed
Has Results
Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: AZD2281;   Drug: matching placebo
14 Withdrawn Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
Condition: Ovarian Cancer
Intervention: Procedure: quality-of-life assessment
15 Completed A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer
Intervention: Biological: DCVac-L
16 Active, not recruiting Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Intervention: Procedure: Tumor collection
17 Completed
Has Results
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: decitabine
18 Recruiting Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Interventions: Drug: Paclitaxel(intravenous) + Carboplatin(intravenous);   Drug: Paclitaxel(intravenous) + Carboplatin(intraperitoneal)
19 Terminated Clinical Trial for Ovarian Cancer (OvaRex®)
Condition: Ovarian Cancer
Intervention: Drug: oregovomab
20 Recruiting Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Chemotherapy;   Tumor;   Ovarian Cancer
Intervention: Biological: OCDC

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years